Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
15.90
-0.85 (-5.07%)
Nov 2, 2026, 4:00 PM EST - Market closed
Beta Bionics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $25.1. The average 1-year stock price forecast is 57.86% higher than the current stock price, while the lowest is $16 (+0.63%) and the highest is $30.4 (+91.19%).
Price Target: $25.1 (+57.86%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 3 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 12 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +88.68% | Oct 29, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $22 | Buy | Maintains | $22 | +38.36% | Oct 28, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | +32.08% | Oct 28, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 | Buy | Maintains | $28 | +76.10% | Oct 28, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 → $24 | Buy | Reiterates | $20 → $24 | +50.94% | Oct 28, 2026 |
Financial Forecast
Revenue This Year
125.54M
from 100.25M
Increased by 25.22%
Revenue Next Year
184.65M
from 125.54M
Increased by 47.09%
EPS This Year
-1.83
from -1.38
EPS Next Year
-2.18
from -1.83
EPS and Forward PE are based on non-GAAP adjusted numbers.